Clin2
NCT06771245Likely a fitNot yet recruiting

Testing a new combo pill for high blood pressure

Mild-to-moderate Essential Hypertension

Treatments studied

Part of Heart & circulation clinical trials.

This study tests a new combination pill (valsartan plus levamlodipine) to see if it works better than current treatments for people with mild to moderate high blood pressure. It may be an option if your current medication isn't controlling your blood pressure well enough.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
606 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • Your body mass index (BMI) is between 18 and 35, and you weigh at least 110 pounds (women) or 110 pounds (men).
  • You have been diagnosed with mild or moderate high blood pressure.
  • Your average blood pressure reading (sitting, taken three times) is between 140/90 and 179/109 while not on medication, or between 140/90 and 179/109 after switching to a low dose of one of the study drugs.
  • You are able to take study pills correctly 80% to 120% of the time during a short run-in period.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06608472Not yet recruiting· Phase 3
Testing a two-medicine combo pill for high blood pressure

This study tests a new combination pill that could control high blood pressure better than current medications alone. It is for adults whose blood pressure remains too high despite taking one or two medicines.

Itapevi, São Paulo
NCT07228065Enrolling by invitation
Combination pill study for better blood pressure control

This trial tests whether switching to a single pill that combines two blood pressure medicines helps control high blood pressure better than taking two separate pills. It might make treatment simpler and more effective.

Milwaukee, Wisconsin
NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT07708441Not yet recruiting· Phase 2/Phase 3
Testing a new pill for hard-to-treat high blood pressure

This trial tests a new medication (HRS-1780) for people whose high blood pressure is not well controlled, even with current treatments. It may help lower blood pressure effectively.

Chongqing, Chongqing Municipality
NCT07373613Not yet recruiting· Phase 2
Testing new drugs for high blood pressure

This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.

Soeul
NCT07486453Not yet recruiting· Phase 1
Comparing a blood pressure combination tablet's absorption

This trial checks how a new combination blood pressure pill (sacubitril, alisartan, and amlodipine) is absorbed by the body compared to other forms. It is for healthy adults with normal to mildly elevated blood pressure.

Hefei, Anhui

Hear when a new Mild-to-moderate Essential Hypertension trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.